How Infection and Vaccination Are Linked to Acute and Chronic Urticaria: A Special Focus on COVID-19

Since more than a century ago, there has been awareness of the connection between viral infections and the onset and exacerbation of urticaria. Our knowledge about the role of viral infection and vaccination in acute and chronic urticaria improved as a result of the COVID-19 pandemic but it has also highlighted knowledge gaps. Viral infections, especially respiratory tract infections like COVID-19, can trigger the onset of acute urticaria (AU) and the exacerbation of chronic urticaria (CU). Less frequently, vaccination against viruses including SARS-CoV-2 can also lead to new onset urticaria as well as worsening of CU in minority. Here, with a particular focus on COVID-19, we review what is known about the role of viral infections and vaccinations as triggers and causes of acute and chronic urticaria. We also discuss possible mechanistic pathways and outline the unmet needs in our knowledge. Although the underlying mechanisms are not clearly understood, it is believed that viral signals, medications, and stress can activate skin mast cells (MCs). Further studies are needed to fully understand the relevance of viral infections and vaccinations in acute and chronic urticaria and to better clarify causal pathways.

[1]  M. Maurer,et al.  Features of Chronic Spontaneous Urticaria Induced by COVID-19 , 2023, International Archives of Allergy and Immunology.

[2]  R. Hui,et al.  Characteristics of immune response profile in patients with immediate allergic and autoimmune urticarial reactions induced by SARS-CoV-2 vaccines , 2023, Journal of autoimmunity.

[3]  S. Frischbutter,et al.  Chronic urticaria and the pathogenic role of mast cells. , 2023, Allergology international : official journal of the Japanese Society of Allergology.

[4]  M. Maurer,et al.  Virus‐infected mast cells activate virus‐specific CD8+ T cells , 2023, Scandinavian Journal of Immunology.

[5]  V. Furer,et al.  Development of Autoantibodies Following BNT162b2 mRNA COVID-19 Vaccination and Their Association with Disease Flares in Adult Patients with Autoimmune Inflammatory Rheumatic Diseases (AIIRD) and the General Population: Results of 1-Year Prospective Follow-Up Study , 2023, Vaccines.

[6]  O. Duperrex,et al.  Incidence of Chronic Spontaneous Urticaria Following Receipt of the COVID-19 Vaccine Booster in Switzerland , 2023, JAMA network open.

[7]  Y. Ohira,et al.  Cholinergic Urticaria After COVID-19 Infection , 2022, The American Journal of Medicine.

[8]  P. Tuchinda,et al.  Disease activity of patients with chronic urticaria receiving COVID-19 vaccines. , 2022, Asian Pacific journal of allergy and immunology.

[9]  Silada Kanokrungsee,et al.  Can mRNA COVID‐19 vaccines induce flares of chronic urticaria? , 2022, Journal of Cosmetic Dermatology.

[10]  F. Mori,et al.  Relapse or worsening of chronic spontaneous urticaria during SARS-CoV-2 infection and vaccination in children: A telemedicine follow-up. , 2022, Allergologia et immunopathologia.

[11]  G. Fabbrocini,et al.  Urticaria relapse after mRNA COVID‐19 vaccines in patients affected by chronic spontaneous urticaria and treated with antihistamines plus omalizumab: A single‐center experience , 2022, Dermatologic therapy.

[12]  M. Maurer,et al.  Urticaria , 2022, Nature Reviews Disease Primers.

[13]  P. Gisondi,et al.  Cutaneous Adverse Reactions to SARS-CoV-2 Vaccines: A Systematic Review and Meta-Analysis , 2022, Vaccines.

[14]  C. Ribi,et al.  Clinical and immunological data from chronic urticaria onset after mRNA SARS‐CoV‐2 vaccines , 2022, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[15]  S. Lipner,et al.  Curbing COVID-19 Vaccine Hesitancy from a Dermatological Standpoint: Analysis of Cutaneous Reactions in the Vaccine Adverse Event Reporting System (VAERS) Database , 2022, American Journal of Clinical Dermatology.

[16]  E. Freeman,et al.  Urticaria and/or angioedema secondary to mRNA COVID‐19 vaccines: Updates from a United States case registry , 2022, Allergy.

[17]  P. Ochieng,et al.  COVID-19 Vaccine Booster-Induced Dermatographism , 2022, Cureus.

[18]  Ö. Yılmaz,et al.  Angioedema Related to Infectious Mononucleosis , 2022, Trends in Pediatrics.

[19]  Brenda Chiang,et al.  Coronavirus disease-19 infection and angioedema in African Americans: A case series , 2022, Otolaryngology Case Reports.

[20]  M. Mirsaeidi,et al.  SARS-CoV-2 cell entry beyond the ACE2 receptor , 2022, Molecular Biology Reports.

[21]  J. Phannajit,et al.  Global prevalence and clinical manifestations of cutaneous adverse reactions following COVID‐19 vaccination: A systematic review and meta‐analysis , 2022, Journal of the European Academy of Dermatology and Venereology : JEADV.

[22]  M. Maurer,et al.  Autoimmune chronic spontaneous urticaria. , 2022, The Journal of allergy and clinical immunology.

[23]  E. Freeman,et al.  Chronic spontaneous urticaria after COVID-19 primary vaccine series and boosters , 2022, JAAD Case Reports.

[24]  L. de Montjoye,et al.  Chronic spontaneous urticaria following COVID-19 vaccination , 2022, JAAD Case Reports.

[25]  R. M. McLarney,et al.  Yellow Urticaria. , 2022, JAMA dermatology.

[26]  G. Pellacani,et al.  Effects of Vaccination against COVID-19 in Chronic Spontaneous and Inducible Urticaria (CSU/CIU) Patients: A Monocentric Study , 2022, Journal of clinical medicine.

[27]  Adrian Y. S. Lee,et al.  Chronic spontaneous urticaria following ChAdOx1-S COVID-19 vaccination , 2022, Allergo Journal International.

[28]  D. Brǎnișteanu,et al.  Mucocutaneous lesions associated with SARS-CoV-2 infection (Review) , 2022, Experimental and therapeutic medicine.

[29]  C. Janson,et al.  Allergies and COVID‐19 vaccines: An ENDA/EAACI Position paper , 2022, Allergy.

[30]  Xiaoqing Fu,et al.  Urticaria and/or angioedema events secondary to mRNA COVID-19 vaccinations - Updates from a national case registry , 2022, Journal of Allergy and Clinical Immunology.

[31]  F. Sodeifian,et al.  Cutaneous manifestation of COVID-19: What have we learned an year into the pandemic? , 2022, Actas Dermo-Sifiliográficas.

[32]  G. Aytekin,et al.  The course of COVID-19 in patients with chronic spontaneous urticaria receiving omalizumab treatment , 2022, Revue Française d'Allergologie.

[33]  L. Rello,et al.  Experience with Cutaneous Manifestations in COVID-19 Patients during the Pandemic , 2022, Journal of clinical medicine.

[34]  A. Linē,et al.  Early and strong antibody responses to SARS-CoV-2 predict disease severity in COVID-19 patients , 2022, Journal of translational medicine.

[35]  S. Chiarella,et al.  Delayed systemic urticarial reactions following mRNA COVID-19 vaccination. , 2022, Allergy and asthma proceedings.

[36]  I. Green,et al.  Chronic spontaneous urticaria after BNT162b2 mRNA (Pfizer-BioNTech) vaccination against SARS-CoV-2. , 2022, Allergy and asthma proceedings.

[37]  M. Abbaslou,et al.  Chronic Spontaneous Urticaria Triggered by the AstraZeneca/Oxford COVID-19 Vaccine with Achieved Remission: A Case Report , 2022, Allergy & rhinology.

[38]  N. Garrett,et al.  Allergic reactions to the Ad26.COV2.S Vaccine in South Africa , 2021, Journal of Allergy and Clinical Immunology: Global.

[39]  J. Klaewsongkram,et al.  Acute urticaria alone after CoronaVac COVID‐19 vaccination should not be a contraindication for revaccination , 2021, Clinical and experimental dermatology.

[40]  Duygu Gulseren,et al.  The effect of COVID‐19 on patients with chronic spontaneous urticaria treated with omalizumab and antihistamines: A cross‐sectional, comparative study , 2021, Journal of cosmetic dermatology.

[41]  N. Conlon,et al.  Rapid transition to home omalizumab treatment for chronic spontaneous urticaria during the COVID-19 pandemic: A patient perspective , 2021, World Allergy Organization Journal.

[42]  T. Zuberbier,et al.  The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria , 2021, Allergy.

[43]  E. Wherry,et al.  New-onset IgG autoantibodies in hospitalized patients with COVID-19 , 2021, Nature Communications.

[44]  H. Miot,et al.  COVID‐19 and skin diseases: results from a survey of 843 patients with atopic dermatitis, psoriasis, vitiligo and chronic urticaria , 2021, Journal of the European Academy of Dermatology and Venereology : JEADV.

[45]  D. Rosmarin,et al.  Comparison of constitutional and dermatologic side effects between COVID-19 and non–COVID-19 vaccines: Review of a publicly available database of vaccine side effects , 2021, Journal of the American Academy of Dermatology.

[46]  George Thomas,et al.  Chronic Spontaneous Urticaria After COVID-19 Vaccine , 2021, Cureus.

[47]  I. Muntean,et al.  COVID-19 Disease Leading to Chronic Spontaneous Urticaria Exacerbation: A Romanian Retrospective Study , 2021, Healthcare.

[48]  N. Rezaei,et al.  [Artículo traducido] Manifestaciones cutáneas de la COVID-19: ¿Qué hemos aprendido tras un año de pandemia? , 2021, Actas Dermo-Sifiliográficas.

[49]  V. Khavinson,et al.  Homology between SARS CoV-2 and human proteins , 2021, Scientific Reports.

[50]  M. Rudenko The Role of Infection and Autoimmunity in Urticaria and Angioedema as a Common Entity , 2021, EMJ Allergy & Immunology.

[51]  I. Zalaudek,et al.  Synthesis of the Data on COVID-19 Skin Manifestations: Underlying Mechanisms and Potential Outcomes , 2021, Clinical, cosmetic and investigational dermatology.

[52]  A. Ołdakowska,et al.  Urticaria multiforme in a child with SARS-CoV-2 infection , 2021, Dermatology reports.

[53]  M. Llamas-Velasco,et al.  Cutaneous reactions after SARS‐CoV‐2 vaccination: a cross‐sectional Spanish nationwide study of 405 cases , 2021, The British journal of dermatology.

[54]  Ş. Beyaz,et al.  Psychological burden of COVID-19 on mild and moderate chronic spontaneous urticarial. , 2021, Allergy and asthma proceedings.

[55]  Paige G. Wickner,et al.  Incidence of Cutaneous Reactions After Messenger RNA COVID-19 Vaccines. , 2021, JAMA dermatology.

[56]  Paige G. Wickner,et al.  Allergic symptoms after mRNA COVID-19 vaccination and risk of incomplete vaccination , 2021, The Journal of Allergy and Clinical Immunology: In Practice.

[57]  J. Quaresma,et al.  Adverse events of the yellow fever vaccine in chronic urticaria: evaluation of patients treated or not with omalizumab compared to healthy individuals☆☆☆ , 2021, Anais brasileiros de dermatologia.

[58]  N. Tsankov,et al.  Cutaneous adverse effects of the available COVID-19 vaccines , 2021, Clinics in Dermatology.

[59]  Joon Seo Lim,et al.  Adverse Reactions Following the First Dose of ChAdOx1 nCoV-19 Vaccine and BNT162b2 Vaccine for Healthcare Workers in South Korea , 2021, Journal of Korean medical science.

[60]  L. Naldi,et al.  Time of Onset of Selected Skin Lesions Associated with COVID-19: A Systematic Review , 2021, Dermatology and Therapy.

[61]  M. Maurer,et al.  Markers for the involvement of endothelial cells and the coagulation system in chronic urticaria: A systematic review , 2021, Allergy.

[62]  J. Lipoff,et al.  Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases , 2021, Journal of the American Academy of Dermatology.

[63]  Ryan D. Morin,et al.  Mast Cell and Eosinophil Activation Are Associated With COVID-19 and TLR-Mediated Viral Inflammation: Implications for an Anti-Siglec-8 Antibody , 2021, Frontiers in Immunology.

[64]  F. Rodieux,et al.  Viral Infections and Cutaneous Drug-Related Eruptions , 2021, Frontiers in Pharmacology.

[65]  V. Koumaki,et al.  Childhood Acute Urticaria and Seasonal Patterns Presenting in the Emergency Department of a Teaching Hospital in London, United Kingdom , 2021, Pediatric emergency care.

[66]  A. Vojdani,et al.  Reaction of Human Monoclonal Antibodies to SARS-CoV-2 Proteins With Tissue Antigens: Implications for Autoimmune Diseases , 2021, Frontiers in Immunology.

[67]  G. Fabbrocini,et al.  The clinical spectrum of COVID-19–associated cutaneous manifestations: An Italian multicenter study of 200 adult patients , 2021, Journal of the American Academy of Dermatology.

[68]  J. Lipoff,et al.  Long COVID in the skin: a registry analysis of COVID-19 dermatological duration , 2021, The Lancet Infectious Diseases.

[69]  Fernanda Bellodi Schmidt,et al.  Acute urticaria preceding other COVID‐19–associated manifestations—A case report , 2021, Pediatric dermatology.

[70]  J. Vrieze Suspicions grow that nanoparticles in Pfizer’s COVID-19 vaccine trigger rare allergic reactions , 2020, Science.

[71]  A. Lavezzi,et al.  Neuropathological explanation of minimal COVID-19 infection rate in newborns, infants and children – a mystery so far. New insight into the role of Substance P , 2020, Journal of the Neurological Sciences.

[72]  Y. Tam,et al.  Skin manifestations of COVID-19: A worldwide review , 2020, JAAD International.

[73]  T. Zuberbier,et al.  The global impact of the COVID‐19 pandemic on the management and course of chronic urticaria , 2020, Allergy.

[74]  T. Theoharides Potential association of mast cells with coronavirus disease 2019 , 2020, Annals of Allergy, Asthma & Immunology.

[75]  S. Aronin,et al.  COVID-19 (SARS-CoV-2) infection presenting as acute urticaria , 2020, Clinics in Dermatology.

[76]  S. Algaadi Urticaria and COVID‐19: A review , 2020, Dermatologic therapy.

[77]  M. Idzko,et al.  Use of biologicals in allergic and type-2 inflammatory diseases during the current COVID-19 pandemic , 2020, Allergologie select.

[78]  C. Pagliari,et al.  What the physicians should know about mast cells, dendritic cells, urticaria, and omalizumab during COVID‐19 or asymptomatic infections due to SARS‐CoV‐2? , 2020, Dermatologic therapy.

[79]  R. Thangavel,et al.  COVID-19, Mast Cells, Cytokine Storm, Psychological Stress, and Neuroinflammation , 2020, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[80]  F. Marceau,et al.  Measurement of Bradykinin Formation and Degradation in Blood Plasma: Relevance for Acquired Angioedema Associated With Angiotensin Converting Enzyme Inhibition and for Hereditary Angioedema Due to Factor XII or Plasminogen Gene Variants , 2020, Frontiers in Medicine.

[81]  V. Bogin,et al.  Clinical characteristics of dermatologic manifestations of COVID‐19 infection: case series of 15 patients, review of literature, and proposed etiological classification , 2020, International journal of dermatology.

[82]  A. S. St. John,et al.  Protective and pathogenic roles for mast cells during viral infections , 2020, Current Opinion in Immunology.

[83]  M. Triggiani,et al.  Risk and management of patients with mastocytosis and MCAS in the SARS-CoV-2 (COVID-19) pandemic: Expert opinions , 2020, Journal of Allergy and Clinical Immunology.

[84]  M. Fernández-Guarino,et al.  Urticarial vasculitis in COVID‐19 infection: a vasculopathy‐related symptom? , 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.

[85]  J. Saurat,et al.  Clinical and Histopathological Features and Potential Pathological Mechanisms of Skin Lesions in COVID-19: Review of the Literature , 2020, Dermatopathology.

[86]  J. Lipoff,et al.  The spectrum of COVID-19–associated dermatologic manifestations: An international registry of 716 patients from 31 countries , 2020, Journal of the American Academy of Dermatology.

[87]  A. Vojdani,et al.  Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases , 2020, Clinical Immunology.

[88]  A. Friedman,et al.  COVID-19 Pandemic: Are There Unique Cutaneous Manifestations in Patients Infected With SARS-CoV-2? , 2020, Journal of drugs in dermatology : JDD.

[89]  C. A. González-Cruz,et al.  Classification of the cutaneous manifestations of COVID‐19: a rapid prospective nationwide consensus study in Spain with 375 cases , 2020, The British journal of dermatology.

[90]  S. Saussez,et al.  Acute urticaria with pyrexia as the first manifestations of a COVID‐19 infection , 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.

[91]  David Berlin,et al.  Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases , 2020, Translational Research.

[92]  É. Estève,et al.  Urticarial eruption in COVID‐19 infection , 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.

[93]  C. Akdis,et al.  Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China , 2020, Allergy.

[94]  A. Dudeck,et al.  Mast cells initiate the vascular response to contact allergens by sensing cell stress. , 2020, The Journal of allergy and clinical immunology.

[95]  L. Bielory,et al.  Mast Cell Biology at Molecular Level: a Comprehensive Review , 2019, Clinical Reviews in Allergy & Immunology.

[96]  M. Maurer,et al.  A case of dengue fever presenting with acute urticaria. , 2019, Asian Pacific journal of allergy and immunology.

[97]  A. Didierlaurent,et al.  The how’s and what’s of vaccine reactogenicity , 2019, npj Vaccines.

[98]  J. Marshall,et al.  Mast Cell Responses to Viruses and Pathogen Products , 2019, International journal of molecular sciences.

[99]  M. Maurer,et al.  Treatment of urticarial vasculitis: A systematic review , 2019, The Journal of allergy and clinical immunology.

[100]  Jing-Yang Huang,et al.  Patients with urticaria are at a higher risk of anaphylaxis: A nationwide population‐based retrospective cohort study in Taiwan , 2018, The Journal of dermatology.

[101]  M. Maurer,et al.  Comorbidity of viral hepatitis and chronic spontaneous urticaria: A systematic review , 2018, Allergy.

[102]  Y. Shoenfeld,et al.  Vaccine-induced autoimmunity: the role of molecular mimicry and immune crossreaction , 2018, Cellular & Molecular Immunology.

[103]  F. Redegeld,et al.  Non‐IgE mediated mast cell activation , 2018, Immunological reviews.

[104]  D. Metcalfe,et al.  Mast cells signal their importance in health and disease. , 2018, The Journal of allergy and clinical immunology.

[105]  W. Busse,et al.  Enhanced plasmacytoid dendritic cell antiviral responses after omalizumab , 2017, The Journal of allergy and clinical immunology.

[106]  E. Iemoli,et al.  Successful Omalizumab treatment in HIV positive patient with chronic spontaneous urticaria: a case report. , 2017, European annals of allergy and clinical immunology.

[107]  Shakeel Ahmed,et al.  Hepatitis C seropositivity in patients with acute and chronic urticaria , 2016 .

[108]  J. Mishal,et al.  The clinical and laboratory characteristics of acute spontaneous urticaria and its progression to chronic spontaneous urticaria. , 2016, Allergy and asthma proceedings.

[109]  J. Bousquet,et al.  Definition, aims, and implementation of GA2LEN Urticaria Centers of Reference and Excellence , 2016, Allergy.

[110]  D. Metcalfe,et al.  IL-6 promotes an increase in human mast cell numbers and reactivity through suppression of suppressor of cytokine signaling 3. , 2016, The Journal of allergy and clinical immunology.

[111]  M. Levi,et al.  Epidemiology of chronic spontaneous urticaria: results from a nationwide, population‐based study in Italy , 2016, The British journal of dermatology.

[112]  D. Dreyfus,et al.  Serological evidence that activation of ubiquitous human herpesvirus‐6 (HHV‐6) plays a role in chronic idiopathic/spontaneous urticaria (CIU) , 2016, Clinical and experimental immunology.

[113]  S. Bulfone-Paus,et al.  Mast Cells as Regulators of T Cell Responses , 2015, Front. Immunol..

[114]  A. Graham,et al.  Mast Cells and Influenza A Virus: Association with Allergic Responses and Beyond , 2015, Front. Immunol..

[115]  M. Becker,et al.  Mast cells: innate attractors recruiting protective CD8 T cells to sites of cytomegalovirus infection , 2015, Medical Microbiology and Immunology.

[116]  T. Xiao,et al.  Acute Urticaria Caused By Infection In 72 Chinese Patients , 2014 .

[117]  S. Adler,et al.  Herpesvirus-Associated Acute Urticaria: An Age Matched Case-Control Study , 2013, PloS one.

[118]  B. Wedi,et al.  Management of childhood urticaria: current knowledge and practical recommendations. , 2013, Acta dermato-venereologica.

[119]  G. Karakaya,et al.  The general characteristics of acute urticaria attacks and the factors predictive of progression to chronic urticaria. , 2013, Allergologia et immunopathologia.

[120]  D. Kevat,et al.  Chronic urticaria following acute hepatitis A , 2012, BMJ Case Reports.

[121]  D. Dreyfus Autoimmune disease: A role for new anti-viral therapies? , 2011, Autoimmunity reviews.

[122]  Rob van Aalsburg,et al.  Urticaria and Periorbital Edema as Prodromal Presenting Signs of Acute Hepatitis B Infection , 2011 .

[123]  N. Papadopoulos,et al.  Childhood acute urticaria in northern and southern Europe shows a similar epidemiological pattern and significant meteorological influences , 2011, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[124]  M. Masi,et al.  Allergy is not the main trigger of urticaria in children referred to the emergency room , 2010, Journal of the European Academy of Dermatology and Venereology : JEADV.

[125]  K. Godse,et al.  Chronic urticaria associated with recurrent genital herpes simplex infection and success of antiviral therapy--a report of two cases. , 2010, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[126]  R. Platt,et al.  Outpatient urticaria diagnosis codes have limited predictive value for same-day influenza vaccine adverse event detection. , 2010, Journal of clinical epidemiology.

[127]  S. Arias-Santiago,et al.  [Cold urticaria associated with Epstein barr virus mononucleosis]. , 2009, Actas dermo-sifiliograficas.

[128]  S. Arias-Santiago,et al.  Urticaria a frigore asociada a mononucleosis por virus de Epstein-Barr , 2009 .

[129]  P. Altmeyer,et al.  Urticaria associated with Norovirus infection: Report of two cases , 2008, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[130]  Yan-Ren Lin,et al.  First attack of acute urticaria in pediatric emergency department. , 2008, Pediatrics and neonatology.

[131]  S. Jiamton,et al.  Acute urticaria: etiologies, clinical course and quality of life. , 2008, Asian Pacific journal of allergy and immunology.

[132]  D. Lipsker,et al.  Acute urticaria and dry cough with interstitial pneumonia: a clue for the diagnosis of primary parvovirus B19 infection , 2006, Clinical and experimental dermatology.

[133]  B. Cribier Urticaria and hepatitis , 2006, Clinical reviews in allergy & immunology.

[134]  B. Wedi,et al.  Chronic urticaria and infections , 2004, Current opinion in allergy and clinical immunology.

[135]  C. Grattan,et al.  Drug-induced urticaria , 2004, Expert opinion on drug safety.

[136]  C. Saçkesen,et al.  The Etiology of Different Forms of Urticaria in Childhood , 2004, Pediatric dermatology.

[137]  S. Nikkari,et al.  Presence of parvovirus B19 DNA in chronic urticaric and healthy human skin. , 2002, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[138]  N. Naing,et al.  Cutaneous manifestations in HIV positive patients. , 2001, The Southeast Asian journal of tropical medicine and public health.

[139]  J. Pijoan,et al.  [Round Table: Urticaria in relation to infections]. , 1999, Allergologia et immunopathologia.

[140]  A. Taïeb,et al.  Acute urticaria in infancy and early childhood: a prospective study. , 1998, Archives of dermatology.

[141]  R. Yu,et al.  Cold urticaria, raised IgE and HIV infection. , 1995, Journal of the Royal Society of Medicine.

[142]  R. Sutter,et al.  Adverse reactions to tetanus toxoid. , 1994, JAMA.

[143]  T. Aoki,et al.  Acute Urticaria: History and Natural Course of 50 Cases , 1994, The Journal of dermatology.

[144]  P. Puska,et al.  Effect of PUVA on immunologic and virologic findings in HIV-infected patients. , 1991, Journal of the American Academy of Dermatology.

[145]  A. Taïeb,et al.  Urticaria in Infants: A Study of Forty Patients , 1990, Pediatric dermatology.

[146]  R. Sorensen,et al.  URTICARIA FOLLOWING ADMINISTRATION OF DIPHTHERIA-TETANUS TOXOIDS-PERTUSSIS VACCINE , 1987 .

[147]  C. LópezSerrano,et al.  Cold urticaria associated with serologic markers of hepatitis B and cryoglobulinemia , 1987 .

[148]  J. Schirm,et al.  Cold urticaria and virus infections: a clinical and serological study in 39 patients , 1986, The British journal of dermatology.

[149]  H. Hurley,et al.  Urticaria as a sign of viral hepatitis. , 1972, Archives of dermatology.

[150]  R. Champion,et al.  URTICARIA AND ANGIO‐OEDEMA , 1969, The British journal of dermatology.

[151]  Sheldon Jm,et al.  The vexing urticaria problem: present concepts of etiology and management. , 1954, The Journal of allergy.

[152]  Ö. Özdemir Parainfluenza Type 3 Virus as an Etiological Cause of Acute Urticaria In a Patient , 2020 .

[153]  Journal Ijar,et al.  THE EFFECT OF TAURINE ON METHOTREXATE INDUCED HEPATORENAL TOXICITY IN RATS. , 2018 .

[154]  S. Gangemi,et al.  Association between urticaria and virus infections: A systematic review. , 2016, Allergy and asthma proceedings.

[155]  Ruth A Sabroe Acute urticaria. , 2014, Immunology and allergy clinics of North America.

[156]  H. Yingying,et al.  The relationship between chronic urticaria and hepatitis B virus infection. , 2009 .

[157]  B. Wedi,et al.  Urticaria and infections , 2009 .

[158]  T. Uyeki,et al.  Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008. , 2008, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[159]  S. Miyake,et al.  Invariant natural killer T (iNKT) cells in asthma: a novel insight into the pathogenesis of asthma and the therapeutic implication of glycolipid ligands for allergic diseases. , 2007, Allergology international : official journal of the Japanese Society of Allergology.

[160]  F. Granata,et al.  Role of superallergens in allergic disorders. , 2007, Chemical immunology and allergy.

[161]  M. T. Caballero,et al.  Epidemiology of urticaria in Spain. , 2004, Journal of investigational allergology & clinical immunology.

[162]  C. Bridges,et al.  Prevention and control of influenza : recommendations of the Advisory Committee on Immunization Practices (ACIP) , 2004 .

[163]  Lead Visual Information Specialist , 2001 .

[164]  U. Bauer,et al.  [Centers for Disease Control and Prevention (CDC)]. , 2000, Annales de dermatologie et de venereologie.

[165]  D. Metcalfe,et al.  Mast cells. , 1997, Physiological reviews.

[166]  L. Scully,et al.  Urticaria and acute hepatitis A virus infection. , 1993, The American journal of gastroenterology.

[167]  P. Barranco Sanz,et al.  [Cold urticaria associated with serologic markers of hepatitis B and cryoglobulinemia]. , 1987, Allergologia et Immunopathologia.